Hodgkin lymphoma: open trials in United States

76 open trials have a site in United States. Registry data; only the trial team decides who can take part.

NCT02682667
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Research · National Cancer Institute (NCI)
National Institutes of Health Clinical Center, Bethesda
Registry updated 2026-11-05
NCT03125642
Auto Stem Cell Transplant for Lymphoma Patients
Trial Treatment · Phase 2 · Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota, Minneapolis
Registry updated 2026-11-04
NCT06150664
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Trial Treatment · Phase 1 · Compass Therapeutics
University Cancer & Blood Center, Athens · University of Alabama, Birmingham · Beth Israel Deaconess Medical Center, Boston · Dana-Farber Cancer Institute, Boston · Roswell Park Cancer Institute, Buffalo · Fort Wayne Medical Oncology and Hematology, Fort Wayne · D & H Cancer Research Center, Margate · Tennessee Oncology, Nashville · Florida Cancer Specialists - Lake Nona, Orlando · Stanford Cancer Institute, Palo Alto · Florida Cancer Specialists - Sarasota, Sarasota · Summit Cancer Center, Spokane
Registry updated 2026-11-04
NCT07226843
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Trial Treatment · Phase 1 · Eli Lilly and Company
Emory University Hospital, Atlanta · Massachusetts General Hospital, Boston · Dana-Farber Cancer Institute, Boston · The Ohio State University (OSU), Columbus · Texas Oncology - DFW (Sammons CC), Dallas · Colorado Blood Cancer Institute, Denver · City of Hope, Duarte · Baylor College of Medicine, Houston · University of California, Los Angeles (UCLA) - Medical Center, Los Angeles · University of Miami - Sylvester Cancer Center, Miami · Froedtert Hospital and the Medical College of Wisconsin, Milwaukee · Vanderbilt University Medical Center, Nashville · Sarah Cannon Research Institute, Nashville · Columbia University, New York · Oregon Health & Science University (OHSU), Portland · Mayo Clinic - Rochester, Rochester · University of Rochester, Rochester · University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco · Florida Cancer Specialists - Sarasota, Sarasota · Mayo Clinic Scottsdale, Scottsdale · University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance), Seattle
Registry updated 2026-11-04
NCT02727803
Personalized NK Cell Therapy in CBT
Trial Treatment · Phase 2 · M.D. Anderson Cancer Center
M D Anderson Cancer Center, Houston
Registry updated 2026-11-02
NCT03681561
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
Trial Treatment · Phase 1/2 · Veronika Bachanova
University of Illinois Cancer Center, Chicago · Ohio State University Comprehensive Cancer Center, Columbus · Indiana Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis · University of Iowa Hospitals and Clinics, Iowa City · University of Wisconsin, Madison · University of Minnesota, Minneapolis
Registry updated 2026-11-02
NCT07691606
A Study of ARC-02 in B-cell NHL
Trial Treatment · Phase 1 · Taiho Oncology, Inc.
Levine Cancer Institute, Charlotte · Start Cala, Los Angeles · Norton Cancer Institute, Louisville · Froedtert & Medical College of Wisconsin, Milwaukee · Massey Cancer Center, Richmond · Summit Cancer Centers - North Spokane, Spokane
Registry updated 2026-11-02
NCT06131801
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Research · Children's Hospital Medical Center, Cincinnati
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta · Children's Hospital Colorado, Aurora · Cincinnati Children's Hospital Medical Center, Cincinnati · Texas Children's Hospital, Houston · Children's Hospital of Wisconsin, Milwaukee · Children's Hospital of Philadelphia, Philadelphia
Registry updated 2026-10-29
NCT07519772
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
University Hospitals of Cleveland (Site 0113), Cleveland · Colorado Blood Cancer Institute (Site 7000), Denver · Cedar Sinai Cancer Center (Site 0119), Los Angeles · SCRI Oncology Partners (Site 0100), Nashville
Registry updated 2026-10-29
NCT01137643
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Research · UNC Lineberger Comprehensive Cancer Center
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill
Registry updated 2026-10-28
NCT02508038
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Trial Treatment · Phase 1 · University of Wisconsin, Madison
University of Wisconsin Carbone Cancer Center, Madison
Registry updated 2026-10-27
NCT01676805
Tissue Collection for Studies of Lymph Cancer
Research · National Cancer Institute (NCI)
National Institutes of Health Clinical Center, Bethesda
Registry updated 2026-10-26
NCT03618550
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Trial Treatment · Phase 2 · Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Basking Ridge, Basking Ridge · Memorial Sloan Kettering Cancer Center - Commack, Commack · City of Hope Cancer Center (Data collection only), Duarte · Memorial Sloan Kettering Westchester, Harrison · University of Miami (Data collection only), Miami · Memorial Sloan Kettering Monmouth, Middletown · Memorial Sloan Kettering Bergen, Montvale · Memorial Sloan-Kettering Cancer Center, New York · Stanford University Medical Center, Stanford · Memorial Sloan Kettering Nassau, Uniondale
Registry updated 2026-10-23
NCT04099966
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Trial Treatment · Phase 2 · Mitchell Cairo
New York Medical College, Valhalla
Registry updated 2026-10-23
NCT06059391
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Trial Treatment · Phase 2 · City of Hope Medical Center
Northside Hospital, Atlanta · DFCI/BWH Brigham and Women's Hospital, Boston · City of Hope Medical Center, Duarte
Registry updated 2026-10-23
NCT07020533
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Trial Treatment · Phase 1 · City of Hope Medical Center
Northside Hospital, Atlanta · Brigham and Women's Hospital, Boston · City of Hope Medical Center, Duarte
Registry updated 2026-10-23
NCT00923442
Biology Studies of Hematologic Cancers
Research · National Cancer Institute (NCI)
National Institutes of Health Clinical Center, Bethesda
Registry updated 2026-10-21
NCT06395441
Wisconsin Ginseng for Decreasing Cancer Related Fatigue
Trial Treatment · Phase 3 · Mayo Clinic
Mayo Clinic Health System in Albert Lea, Albert Lea · Sanford Joe Lueken Cancer Center, Bemidji · Essentia Health Saint Joseph's Medical Center, Brainerd · Essentia Health - Deer River Clinic, Deer River · Essentia Health St. Mary's Detroit Lakes Clinic, Detroit Lakes · Essentia Health Cancer Center, Duluth · Essentia Health - Fosston, Fosston · Essentia Health Hibbing Clinic, Hibbing · Mayo Clinic Health System Mankato, Mankato · MMCORC CentraCare Monticello Cancer Center, Monticello · Mayo Clinic in Rochester, Rochester · Essentia Health Sandstone, Sandstone · Sanford Thief River Falls Medical Center, Thief River Falls · Essentia Health Virginia Clinic, Virginia · Sanford Worthington Medical Center, Worthington
Registry updated 2026-10-20
NCT07021989
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Trial Treatment · Phase 2 · Michael Spinner, MD
University of California, Davis, Davis · University of California San Francisco-Fresno, Fresno · University of California, Irvine, Irvine · University of California San Diego, La Jolla · Unversity of California, Los Angeles, Los Angeles · University of California San Francisco, San Francisco
Registry updated 2026-10-20
NCT06526793
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Trial Treatment · Phase 2 · AstraZeneca
Austin · Charlotte · Chicago · Columbus · Duarte · Houston · Iowa City · Jacksonville · Milwaukee · Nashville · New Brunswick · New York · Overland Park · Philadelphia · Phoenix · Pittsburgh · Portland · Rochester · San Antonio · St Louis · Tampa · Waukee
Registry updated 2026-10-14
NCT00131014
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
Research · Dana-Farber Cancer Institute
Dana-Farber Cancer Institute, Boston
Registry updated 2026-10-13
NCT06137144
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
Atlanta · Boston · Duarte · Houston · Miami · New York · Philadelphia
Registry updated 2026-10-13
NCT06173518
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Trial Treatment · Phase 1 · Autolus Limited
Children's Hospital Colorado, Aurora · Lurie Children's Hospital, Chicago · Cincinnati Children's Hospital, Cincinnati · Children's Hospital Los Angeles, Los Angeles · Lucile Packard Children's Hospital Stanford University, Palo Alto · Children's Hospital of Philadelphia, Philadelphia · Primary Children's Hospital, Salt Lake City · Methodist Children's Hospital, San Antonio · Seattle Children's Hospital, Seattle
Registry updated 2026-10-09
NCT06806033
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Trial Treatment · Phase 2 · Hoffmann-La Roche
New York Oncology Hematology, P.C., Albany · Alaska Oncology & Hematology, LLC, Anchorage · Rocky Mountain Cancer Centers,LLP, Aurora · Mary Bird Perkins Cancer Ctr, Baton Rouge · St. Luke's Cancer Institute, Boise · Boston Medical Center, Boston · Tennessee Oncology, Chattanooga · Community Cancer Institute (CCI), Clovis · Hematology Oncology Associates of Central New York, East Syracuse · Oncology Associates of Oregon, P.C., Eugene · Virginia Cancer Specialists PC, Fairfax · Providence Medical Foundation, Fullerton · North Florida/ South Georgia VA Medical Center, Gainesville · Los Angeles Cancer Network, Glendale · Corewell Health, Grand Rapids · University of Kentucky/Markey Cancer Center, Lexington · Valkyrie Clinical Trials, Los Angeles · Mount Sinai Comprehensive Cancer Center, Miami · Tennessee Oncology, Nashville · Nebraska Cancer Specialists, Omaha · Orlando Health Cancer Institute, Orlando · Valkyrie Clinical Trials, Panorama City · Providence St. Vincent Medical Center, Portland · Providence Portland Medical Center, Portland · Zuckerberg San Francisco General Hospital, San Francisco · Cancer Care Specialists of Central Illinois, Swansea · Northwest Medical Specialties, Tacoma · Baylor Scott & White Health, Temple · Texas Oncology- Gulf Coast, The Woodlands · The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente, Torrance · Texas Oncology - Northeast Texas, Tyler · Virginia Oncology Associates - Virginia Beach, Virginia Beach · Mission Blood and Cancer - MercyOne Cancer Center, Waukee
Registry updated 2026-10-09
NCT06398457
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Trial Treatment · Early phase 1 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Registry updated 2026-10-05

All Hodgkin lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error